First-ever vaccine for disfiguring skin disease to begin testing in humans | ChicagoLIVE

A vaccine for leishmaniasis years in the making has been developed and approved for testing in humans, with clinical trials set to begin in a few months. Dr. Abhay Satoskar from The Ohio State University Wexner Medical Center joins ChicagoLIVE to talk about what the disease is and the testing process for the vaccine.